Theravance Biopharma Inc
NASDAQ:TBPH
Wall Street
Price Targets
TBPH Price Targets Summary
Theravance Biopharma Inc
According to Wall Street analysts, the average 1-year price target for
TBPH
is 15.71 USD
with a low forecast of 10.1 USD and a high forecast of 22.05 USD.
TBPH Last Price Targets
Theravance Biopharma Inc
The latest public price target was made on Apr 12, 2024 by
Julian Harrison
from
BTIG
,
who expects
TBPH
stock to
rise by 130%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Julian Harrison
BTIG
|
21
USD
Upside 130% |
2 weeks ago
Apr 12, 2024
|
BTIG Starts Theravance Biopharma (TBPH) at Buy
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TBPH's stock price target?
Price Target
15.71
USD
According to Wall Street analysts, the average 1-year price target for
TBPH
is 15.71 USD
with a low forecast of 10.1 USD and a high forecast of 22.05 USD.
What is Theravance Biopharma Inc's Revenue forecast?
Projected CAGR
30%
For the last 8 years the
compound annual growth rate for
Theravance Biopharma Inc's revenue is
4%.
The projected
CAGR
for the next 3 years is
30%.
You don't have any saved screeners yet
